OSIS

OSI Systems

$0.00

+6.85%
May 22, 2026
Bobby Quantitative Model
OSI Systems Inc designs and manufactures electronic systems and components for critical markets including homeland security, healthcare, defense, and aerospace. The company operates as a specialized technology provider across three segments, with its Security division being the largest revenue contributor, focusing on security and inspection systems. The current investor narrative centers on the company's execution within its cyclical government and security contracting business, with recent attention likely driven by quarterly performance, backlog visibility in its Security segment, and its ability to navigate supply chain and geopolitical factors affecting its international sales.

People also watch

Amphenol

Amphenol

APH

Analysis
SanDisk

SanDisk

SNDK

Analysis
Corning Inc.

Corning Inc.

GLW

Analysis
Keysight Technologies

Keysight Technologies

KEYS

Analysis
II-VI Incorporated

II-VI Incorporated

COHR

Analysis

BobbyInvestment Opinion: Should I buy OSIS Today?

Rating: Hold. The core thesis is that OSIS presents a challenging risk/reward profile where strong fundamental improvements are overshadowed by severe technical damage and high volatility, recommending patience for a more favorable entry point or clearer signs of trend reversal.

Supporting Evidence: The Hold rating is anchored by the stock's 24.1% one-month decline placing it near oversold levels, just 9.0% above its 52-week low. Fundamentally, the company's Q2 revenue growth of 10.54% YoY and net margin expansion to 8.34% are positive, as is the robust TTM free cash flow of $142.3 million. However, the forward P/E of 19.41x, while lower than trailing, still implies growth expectations that may be challenged by the stock's high beta of 1.31 and the lack of a clear analyst price target for upside calibration.

Risks & Conditions: The two biggest risks are the continuation of the severe downtrend breaking key support at $203.45, and a deceleration in revenue growth below the high-single digits, which would invalidate the growth premium. This Hold would upgrade to a Buy if the stock establishes a firm base above its 52-week low and shows sustained momentum above the $250 level, or if forward earnings estimates are revised meaningfully higher. It would downgrade to a Sell if Q2 margin expansion proves temporary and net income retreats toward Q1 levels, or if revenue growth turns negative. Relative to its own history, the stock is fairly valued after its de-rating, but remains vulnerable given its weak technical posture.

Sign up to view all

OSIS 12-Month Price Forecast

The outlook for OSIS is clouded by high uncertainty. While the fundamental improvement in Q2 is notable, the stock's price action is signaling deep distress and a loss of investor confidence. The high beta and lack of analyst targets make forecasting particularly challenging. The base case of range-bound consolidation is most likely, as the stock digests its massive decline and the market assesses whether the operational rebound is sustainable. The stance would upgrade to bullish on a confirmed technical reversal above $250 accompanied by another quarter of margin strength. It would turn bearish on a breakdown below the $203.45 support level, which would likely signal deeper fundamental issues.

Historical Price
Current Price $222.1
Average Target $255
High Target $311
Low Target $180

Wall Street consensus

Most Wall Street analysts maintain a constructive view on OSI Systems's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.

Average Target

$0.00

4 analysts

Implied Upside

vs. current price

Analyst Count

4

covering this stock

Price Range

$0 - $0

Analyst target range

Buy
1 (25%)
Hold
2 (50%)
Sell
1 (25%)

Analyst coverage for OSIS is limited, with only 4 analysts providing estimates, which is typical for a mid-cap technology hardware company and can lead to higher volatility and less efficient price discovery. The available data shows analyst estimates for EPS and revenue but does not provide a consensus price target, Buy/Hold/Sell distribution, or a target price range. The estimated EPS average is $13.04, with a narrow range from $12.80 to $13.46, indicating strong agreement on near-term earnings prospects. The lack of published price targets suggests investors must rely more heavily on independent valuation work, and the stock's recent dramatic price movement may not yet be fully reflected in formal analyst models. The institutional ratings data shows a pattern of reiterated 'Buy' or 'Outperform' ratings from firms like Roth Capital, B. Riley Securities, and BofA Securities through late 2025 and early 2026, with JP Morgan maintaining a 'Neutral' stance, indicating generally positive but cautious sentiment among the firms that do cover the stock.

Drowning in data?

Find the real signal!

Bulls vs Bears: OSIS Investment Factors

The investment debate for OSIS is a classic clash between deteriorating price action and intact fundamentals. The bear case, currently supported by stronger evidence, is led by the stock's severe technical breakdown, dramatic market underperformance, and high volatility that has punished shareholders. However, the bull case presents a compelling fundamental counter-narrative of rebounding profitability, solid growth, and a healthy financial base, now available at a valuation that has de-rated from extreme levels. The single most important tension is whether the recent catastrophic price decline (-24% in one month) is a rational pricing of heightened risk and slowing growth, or an irrational overreaction that has created a value opportunity in a company demonstrating operational improvement. The resolution hinges on the company's ability to sustain its Q2 margin expansion and double-digit revenue growth in the face of the negative market sentiment clearly reflected in the chart.

Bullish

  • Strong Earnings Rebound & Margin Expansion: Q2 FY2026 net income of $38.7 million represents a significant sequential improvement from Q1's $20.6 million, with net margin expanding from 5.34% to 8.34%. Operating margin also surged to 12.67% from 8.60%, demonstrating effective cost control and operational leverage as revenue grew.
  • Solid Revenue Growth Trajectory: Q2 revenue of $464.1 million grew 10.54% year-over-year, building on a strong Q4 FY2025 base of $505.0 million. This consistent double-digit growth, driven by the Product segment, indicates resilient demand in its core security and healthcare markets despite macroeconomic headwinds.
  • Healthy Balance Sheet & Cash Generation: The company maintains a strong liquidity position with a current ratio of 2.04 and manageable leverage (Debt/Equity of 0.72). Robust TTM free cash flow of $142.3 million provides ample internal funding for operations and potential strategic investments without straining the balance sheet.
  • Forward P/E Suggests Earnings Growth: The forward P/E of 19.41x is substantially lower than the trailing P/E of 25.81x, implying analysts expect significant earnings acceleration. The estimated forward EPS of $13.04, with a tight range among 4 analysts, indicates consensus confidence in near-term profitability.

Bearish

  • Severe Technical Downtrend & Underperformance: OSIS has dramatically underperformed the market, down 2.88% over the past year versus the S&P 500's +27.88% gain, a relative strength deficit of -30.76%. The stock is in a pronounced downtrend, down 24.07% over the past month and 24.17% over three months, indicating persistent and accelerating selling pressure.
  • High Volatility Amplifies Downside Risk: With a beta of 1.31, OSIS is 31% more volatile than the broader market, which has magnified losses during the recent risk-off move. This high volatility, combined with a short ratio of 8.39, suggests the stock is prone to sharp swings and heightened selling pressure from both market moves and short sellers.
  • Valuation Premium & Recent De-rating: The stock trades at a premium sales multiple (P/S of 2.25x, EV/Sales of 2.28x) and a PEG ratio of 1.43, suggesting growth is already priced in. The trailing P/E has compressed from a recent high of 51.22x in Q1 FY2026 to 25.81x, reflecting a market reassessment of growth prospects that may not be complete.
  • Limited Analyst Coverage & Price Discovery: Only 4 analysts provide estimates for OSIS, and no consensus price target is available, leading to less efficient price discovery and higher volatility. While institutional ratings are generally positive, the lack of formal targets means investors lack a clear benchmark, increasing reliance on volatile sentiment.

OSIS Technical Analysis

The stock is in a pronounced downtrend, having declined 2.88% over the past year, which starkly contrasts with the S&P 500's 27.88% gain, resulting in a severe relative strength deficit of -30.76%. With a current price of $222.10, OSIS is trading near the lower end of its 52-week range, positioned just 9.0% above its 52-week low of $203.45 and 28.7% below its high of $311.72, indicating significant technical weakness and potential oversold conditions. Recent momentum has been decisively negative, with the stock down 24.07% over the past month and 24.17% over the past three months, accelerating the longer-term downtrend and suggesting persistent selling pressure. The stock's beta of 1.31 confirms it is approximately 31% more volatile than the broader market, which has amplified losses during this risk-off move. Key technical support is firmly established at the 52-week low of $203.45, while resistance lies at the recent high near $311.72; a decisive break below support could signal a continuation of the downtrend, whereas a recovery above the $250 level would be needed to suggest stabilization. The stock's maximum drawdown of -33.67% over the provided period underscores the high volatility and substantial downside risk inherent in its current price action.

Beta

1.31

1.31x market volatility

Max Drawdown

-33.7%

Largest decline past year

52-Week Range

$203-$312

Price range past year

Annual Return

-2.9%

Cumulative gain past year

PeriodOSIS ReturnS&P 500
1m-24.1%+4.4%
3m-24.2%+8.5%
6m-11.5%+9.7%
1y-2.9%+28.8%
ytd-13.1%+9.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

OSIS Fundamental Analysis

OSIS demonstrates solid revenue growth, with Q2 FY2026 revenue of $464.06 million representing a 10.54% year-over-year increase, building on the strong Q4 FY2025 revenue of $504.99 million. The growth is primarily driven by its Product segment, which contributed $350.76 million in the latest quarter, though the multi-quarter trend shows some variability with sequential declines from Q4 to Q1 before the recent rebound. The company is profitable, posting a net income of $38.70 million in Q2 FY2026, translating to a net margin of 8.34%, which improved significantly from the 5.34% margin in Q1. Gross margin for the quarter was 32.67%, slightly down from 33.32% in Q4 FY2025 but consistent with its historical range, indicating stable pricing power and cost management. Operating income of $58.80 million in Q2 yielded an operating margin of 12.67%, showing a healthy expansion from the 8.60% margin in Q1, reflecting improved operational efficiency. The balance sheet is reasonably healthy with a current ratio of 2.04 and a debt-to-equity ratio of 0.72, indicating manageable leverage. The company generated robust free cash flow of $142.33 million on a TTM basis and an operating cash flow of $62.20 million in the latest quarter, providing internal funding for growth. However, the return on equity of 15.73%, while positive, suggests moderate efficiency in generating profits from shareholder equity.

Quarterly Revenue

$464057000.0B

2025-12

Revenue YoY Growth

+0.10%

YoY Comparison

Gross Margin

+0.32%

Latest Quarter

Free Cash Flow

$142327000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Product
Service

Open an Account, get $2 TSLA now!

Valuation Analysis: Is OSIS Overvalued?

Given a positive net income of $38.70 million, the primary valuation metric is the P/E ratio. The trailing P/E is 25.81x, while the forward P/E is notably lower at 19.41x, indicating the market expects significant earnings growth in the coming year. The gap between trailing and forward multiples suggests analysts are forecasting an earnings acceleration, which aligns with the estimated EPS of $13.04 for the forward period. Compared to sector averages, OSIS trades at a premium on a sales basis, with a P/S ratio of 2.25x and an EV/Sales of 2.28x; specific industry average multiples are not provided in the data for a direct comparison, but the P/E and P/S levels suggest a valuation that factors in its niche market position and growth profile. Historically, the stock's own valuation has compressed significantly; its current trailing P/E of 25.81x is below the recent high of 51.22x seen in Q1 FY2026 and is now closer to levels seen in late 2023 and early 2024 (e.g., 18.56x in Q4 FY2025). This de-rating to a more moderate historical range reflects the market's reassessment of growth prospects and risk following the recent sharp price decline, potentially offering a more reasonable entry point if fundamentals remain intact.

PE

25.8x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 9x~51x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

17.0x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: OSIS faces moderate financial risk, primarily from its exposure to cyclical government spending in its dominant Security segment, which could lead to revenue volatility. While the balance sheet is healthy (D/E 0.72), the company's profitability has shown quarterly swings, with net margin dipping to 5.34% in Q1 FY2026 before recovering to 8.34% in Q2. Dependence on continued execution to justify its forward P/E of 19.4x is a key risk; any stumble in earnings growth could trigger multiple compression. The lack of a dividend also means total return is entirely dependent on share price appreciation, which has been highly volatile.

Market & Competitive Risks: The stock's premium valuation (P/S 2.25x) is vulnerable to compression if growth decelerates or if the market continues to de-rate mid-cap technology hardware stocks. Its high beta of 1.31 makes it sensitive to broader market downturns, as evidenced by its severe underperformance during the recent period. Competitive risks are inherent in its specialized markets, where technological disruption or the loss of a key government contract could materially impact results. The high short interest (short ratio 8.39) indicates a skeptical investor base that can amplify downward moves on any negative news.

Worst-Case Scenario: The worst-case scenario involves a combination of a cyclical downturn in government security spending, a missed earnings quarter that breaks the recent margin recovery trend, and a broader market sell-off that targets high-beta stocks. This could trigger a wave of analyst downgrades (given the limited coverage, each one carries outsized weight) and force covering by the significant short interest in a declining market, creating a vicious cycle. Realistic downside could see the stock retest and break its 52-week low of $203.45, with a further decline toward the $180-$190 range, representing a potential loss of 19-23% from the current price of $222.10. The stock's maximum drawdown of -33.67% over the provided period serves as a historical guide for its downside volatility.

FAQ

The key risks are, in order of severity: 1) Technical & Momentum Risk: The stock is in a severe downtrend, down 24% in one month, with high volatility (beta 1.31) that can amplify losses. 2) Cyclical Revenue Risk: Heavy reliance on the cyclical Security segment for revenue makes the business vulnerable to government budget cycles. 3) Valuation Compression Risk: Trading at a forward P/E of 19.4x, any earnings disappointment could trigger multiple contraction. 4) Limited Coverage Risk: With only 4 analysts, price discovery is less efficient, and the stock can gap on news. The high short ratio of 8.39 also indicates a skeptical investor base ready to press bets on weakness.

The 12-month forecast for OSIS is highly bifurcated, with a 50% probability for a base case range of $240-$270, a 25% probability for a bull case up to $311, and a 25% probability for a bear case down to $180-$203. The base case, which is most likely, assumes the stock consolidates after its severe decline as the company delivers uneven but positive results. The forecast hinges almost entirely on whether the operational improvement seen in Q2 FY2026 (net margin of 8.34%) is sustained. Without analyst price targets, this forecast is derived from technical levels (52-week high/low) and the implied valuation of the forward P/E multiple on estimated earnings.

OSIS appears fairly valued relative to its own history but carries risk relative to its growth prospects. The forward P/E of 19.41x is reasonable if the company meets its estimated EPS of $13.04, representing a significant discount to its trailing P/E of 25.81x. However, the P/S ratio of 2.25x and PEG ratio of 1.43 suggest the market is already pricing in solid growth. The valuation has de-rated sharply from a P/E above 50x earlier in the year, moving from overvalued to a more neutral zone. The current price implies the market expects the company to deliver on its earnings growth forecast but remains skeptical, as reflected in the depressed stock price.

OSIS is a high-risk, high-potential-reward stock that is not a good buy for most investors at this moment. The severe 24% one-month decline and dramatic underperformance versus the market indicate significant negative momentum. While fundamentals showed improvement in Q2 with margin expansion, the stock's high beta of 1.31 and lack of analyst price targets make it a speculative play. It could be a good buy for very risk-tolerant investors who believe the sell-off is overdone and are willing to wait for a technical reversal, but conservative investors should avoid it until a clearer uptrend is established.

OSIS is not suitable for short-term trading due to its high volatility (beta 1.31) and catastrophic recent momentum, which could lead to rapid losses. It is also a challenging long-term hold until the current downtrend is broken, as long-term investors have suffered significant drawdowns (max drawdown -33.67%). The stock is best approached with a medium-term, opportunistic horizon of 12-24 months by investors who can actively monitor its technical recovery and fundamental execution. A minimum holding period should be at least through the next two earnings reports to determine if the Q2 rebound is a new trend or an anomaly.